As I’ve grown older, I’ve become a self-advocate, taking initiative when possible. I’ve developed a close relationship with my…
Tré LaRosa
Tré LaRosa is a scientific project manager, patient advocate, and writer. He has cystic fibrosis (CF) and carries two copies of the F508del mutation. He's been on Trikafta since 2019. He writes about science, living with CF, grief, family, and everything in between in an effort to get you thinking about what it means to be human. He lives in Arlington, Virginia with his fiancée Jessica and their two wonderful, lazy dogs, Duncan and Leo. He enjoys playing sports, being outdoors, and reading — and especially buying more books.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Tré LaRosa
I’ve been on Orkambi (lumacaftor/ivacaftor), a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, for just over three years now. My…
Last in a series. Read part one and part two. The poster sessions at the North American Cystic…
Second in a series. Read part one. The poster sessions at the North American Cystic Fibrosis Conference (NACFC)…
First in a series. The poster sessions at the North American Cystic Fibrosis Conference (NACFC) in Denver this month…
As much as we resist the idea, cystic fibrosis can become a defining part of identity; a lifestyle that we’re…
If you read my column last week, you know I care a lot about the interpretation of words. The…
Please Don’t Label Me as Sick
Speaking as a writer: Words wield heavy power. Our written and spoken words are capable of mightiness. They can impart…
I’ve noticed that there are two schools of thought in the CF community about discussing our life with a chronic…
A strange reality of living with cystic fibrosis (CF) is that we’re usually the only person with the disease we…